211 related articles for article (PubMed ID: 14971604)
21. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial.
Vik TA; Pfluger T; Kadota R; Castel V; Tulchinsky M; Farto JC; Heiba S; Serafini A; Tumeh S; Khutoryansky N; Jacobson AF
Pediatr Blood Cancer; 2009 Jul; 52(7):784-90. PubMed ID: 19185008
[TBL] [Abstract][Full Text] [Related]
22. MIBG in Neuroblastoma Diagnostic Imaging and Therapy.
Sharp SE; Trout AT; Weiss BD; Gelfand MJ
Radiographics; 2016; 36(1):258-78. PubMed ID: 26761540
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
[TBL] [Abstract][Full Text] [Related]
24.
Aboian MS; Huang SY; Hernandez-Pampaloni M; Hawkins RA; VanBrocklin HF; Huh Y; Vo KT; Gustafson WC; Matthay KK; Seo Y
J Nucl Med; 2021 Jan; 62(1):43-47. PubMed ID: 32414950
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Hero B; Hunneman DH; Gahr M; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):220-3. PubMed ID: 11464889
[TBL] [Abstract][Full Text] [Related]
26. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors.
Gelfand MJ; Elgazzar AH; Kriss VM; Masters PR; Golsch GJ
J Nucl Med; 1994 Nov; 35(11):1753-7. PubMed ID: 7965151
[TBL] [Abstract][Full Text] [Related]
27.
Lewington V; Lambert B; Poetschger U; Sever ZB; Giammarile F; McEwan AJB; Castellani R; Lynch T; Shulkin B; Drobics M; Staudenherz A; Ladenstein R
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):234-241. PubMed ID: 27663238
[TBL] [Abstract][Full Text] [Related]
28. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
Sato Y; Hanai J; Takasugi N; Takeda T
Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
[TBL] [Abstract][Full Text] [Related]
29. I-123-MIBG scintigraphy in patients with neuroblastoma.
Rogasch JMM; Amthauer H; Furth C; Hundsdoerfer P; Wedel F; Schatka I
Nuklearmedizin; 2018 Feb; 57(1):35-39. PubMed ID: 29536499
[TBL] [Abstract][Full Text] [Related]
30. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
32. Correlation between iodine-131 MIBG imaging and biological markers in advanced neuroblastoma.
Yeh SD; Helson L; Benua RS
Clin Nucl Med; 1988 Jan; 13(1):46-52. PubMed ID: 3349700
[TBL] [Abstract][Full Text] [Related]
33. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
Melzer HI; Coppenrath E; Schmid I; Albert MH; von Schweinitz D; Tudball C; Bartenstein P; Pfluger T
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1648-58. PubMed ID: 21617976
[TBL] [Abstract][Full Text] [Related]
34. Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis.
Maurea S; Lastoria S; Caracò C; Indolfi P; Casale F; di Tullio MT; Salvatore M
J Nucl Med; 1994 Sep; 35(9):1429-35. PubMed ID: 8071687
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
36. [123I-MIBG scintigraphy in patients with neuroblastoma].
Koizumi M; Sawada H; Goto M; Iijima A; Watari T; Kurosawa H; Kurumada H; Sugita K; Furukawa T
Kaku Igaku; 1994 May; 31(5):507-11. PubMed ID: 8028223
[TBL] [Abstract][Full Text] [Related]
37. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
38. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
[TBL] [Abstract][Full Text] [Related]
39. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
[TBL] [Abstract][Full Text] [Related]
40. [Detection of neural crest tumors by 123I-MIBG scintigraphy].
Ikekubo K; Hino M; Ootsuka H; Ito H; Yamaguchi H; Dan Y; Masui Y; Bito S; Ohta K; Saiki Y
Kaku Igaku; 1994 Nov; 31(11):1357-64. PubMed ID: 7837704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
